These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 34188167)

  • 1. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.
    Su CM; Wang L; Yoo D
    Sci Rep; 2021 Jun; 11(1):13464. PubMed ID: 34188167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation.
    Nishitsuji H; Iwahori S; Ohmori M; Shimotohno K; Murata T
    mBio; 2022 Aug; 13(4):e0097122. PubMed ID: 35856559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 ORF3a positively regulates NF-κB activity by enhancing IKKβ-NEMO interaction.
    Nie Y; Mou L; Long Q; Deng D; Hu R; Cheng J; Wu J
    Virus Res; 2023 Apr; 328():199086. PubMed ID: 36894068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 ORF3a-Mediated NF-κB Activation Is Not Dependent on TRAF-Binding Sequence.
    Busscher BM; Befekadu HB; Liu Z; Xiao TS
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
    Hassan SS; Choudhury PP; Dayhoff GW; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Pizzol D; Adadi P; Lal A; Soares A; Mohamed Abd El-Aziz T; Brufsky AM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Ã; Chauhan G; Palu G; Mishra YK; Barh D; Santana Silva RJ; Andrade BS; Azevedo V; Góes-Neto A; Bazan NG; Redwan EM; Tambuwala M; Uversky VN
    Arch Biochem Biophys; 2022 Mar; 717():109124. PubMed ID: 35085577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
    Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
    mBio; 2021 Feb; 13(1):e0016922. PubMed ID: 35164548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ORF8a as a viroporin in SARS-CoV-2 infection?
    Zandi M
    Cytokine Growth Factor Rev; 2021 Oct; 61():1. PubMed ID: 34362671
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds.
    Elnosary ME; Shreadah MA; Ashour ML; Nabil-Adam A
    Int Immunopharmacol; 2024 Jan; 126():111072. PubMed ID: 38006751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ORF3a of SARS-CoV-2 modulates PI3K/AKT signaling in human lung epithelial cells via hsa-miR-155-5p.
    Ahmad F; Keshri V; Singh SK
    Int J Biol Macromol; 2024 May; 268(Pt 1):131734. PubMed ID: 38653431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway.
    Xu H; Akinyemi IA; Chitre SA; Loeb JC; Lednicky JA; McIntosh MT; Bhaduri-McIntosh S
    Virology; 2022 Mar; 568():13-22. PubMed ID: 35066302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoplasmic reticulum-associated SARS-CoV-2 ORF3a elicits heightened cytopathic effects despite robust ER-associated degradation.
    Zhang J; Cruz-Cosme R; Zhang C; Liu D; Tang Q; Zhao RY
    mBio; 2024 Jan; 15(1):e0303023. PubMed ID: 38078754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication.
    Gowda P; Patrick S; Joshi SD; Kumawat RK; Sen E
    Cytokine; 2021 Jun; 142():155496. PubMed ID: 33773396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19.
    Tian M; Liu W; Li X; Zhao P; Shereen MA; Zhu C; Huang S; Liu S; Yu X; Yue M; Pan P; Wang W; Li Y; Chen X; Wu K; Luo Z; Zhang Q; Wu J
    Signal Transduct Target Ther; 2021 Aug; 6(1):308. PubMed ID: 34408131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling.
    Li TW; Kenney AD; Park JG; Fiches GN; Liu H; Zhou D; Biswas A; Zhao W; Que J; Santoso N; Martinez-Sobrido L; Yount JS; Zhu J
    Front Immunol; 2022; 13():1007089. PubMed ID: 36177032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of miR-9 in Modulating NF-κB Signaling and Cytokine Expression in COVID-19 Patients.
    Prezioso C; Limongi D; Checconi P; Ciotti M; Legramante JM; Petrangeli CM; Leonardis F; Giovannelli A; Terrinoni A; Bernardini S; Minieri M; D'Agostini C
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14
    Zhou Z; Huang C; Zhou Z; Huang Z; Su L; Kang S; Chen X; Chen Q; He S; Rong X; Xiao F; Chen J; Chen S
    iScience; 2021 Mar; 24(3):102187. PubMed ID: 33615195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB.
    Lisi S; Sisto M; Lofrumento DD; D'Amore M
    Lab Invest; 2012 Apr; 92(4):615-24. PubMed ID: 22157716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival.
    DeDiego ML; Nieto-Torres JL; Regla-Nava JA; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodriguez C; Perlman S; Enjuanes L
    J Virol; 2014 Jan; 88(2):913-24. PubMed ID: 24198408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.